Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity-Reference-Cited by-同舟云学术

Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity

Published:2014 Issue: Volume:1 Page:14010
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Leddon Jennifer L,Chen Chun-Yu,Currier Mark A,Wang Pin-Yi,Jung Francesca A,Denton Nicholas L,Cripe Kevin M,Haworth Kellie B,Arnold Michael A,Gross Amy C,Eubank Timothy D,Goins William F,Glorioso Joseph C,Cohen Justus B,Grandi Paola,Hildeman David A,Cripe Timothy P

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference26 articles.

1. Childhood and adolescent cancer statistics, 2014;Ward;CA Cancer J Clin,2014

2. Outcomes for children and adolescents with cancer: challenges for the twenty-first century;Smith;J Clin Oncol,2010

3. Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress;Kaur;Curr Pharm Biotechnol,2012

4. Oncolytic virotherapy reaches adolescence;Hammill;Pediatr Blood Cancer,2010

5. “Buy one get one free”: armed viruses for the treatment of cancer cells and their microenvironment;Kaur;Curr Gene Ther,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelomodulatory treatments augment the therapeutic benefit of oncolytic viroimmunotherapy in murine models of malignant peripheral nerve sheath tumors;Frontiers in Immunology;2024-06-25

2. Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy;Frontiers in Immunology;2024-06-04

3. Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer;Molecular Therapy: Oncology;2024-06

4. Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma;2024-03-03

5. Neoadjuvant use of oncolytic herpes virus G47Δ prevents local recurrence after insufficient resection in tongue cancer models;Molecular Therapy - Oncolytics;2023-09